FLUDOX-400
MRP: 10,500
Packaging: 10x10
Pack Type: tablet
Composition:
Favipiravir 400mg
Indication:
For Treatment of mild moderate cases of COVID-19
Description:
Favipiravir 400 mg is an oral antiviral drug that works by inhibiting the RNA-dependent RNA polymerase enzyme, a key component in the replication process of RNA viruses. Initially developed for influenza, it gained emergency approval in some countries during the COVID-19 pandemic for treating mild to moderate COVID-19.
This higher-strength formulation helps reduce pill burden and enhances patient compliance in cases requiring higher doses. Favipiravir should only be used under physician supervision, especially as part of a prescribed treatment plan in early-stage viral infections.
Tags:
- Effective against a wide range of RNA viruses
- High-dose formulation for reduced tablet intake
- Used in mild to moderate COVID-19 cases
- Helps reduce viral load and disease progression
- Oral therapy with manageable side effect profile
Usage Information
Dosage
Typical Adult Dose: Day 1: 1800 mg twice daily (can be 2 × 400 mg + 1 × 200 mg per dose) Day 2–14: 800 mg twice daily (2 × 400 mg) Should be taken after meals with water Must complete full course as advised by your doctor Do not self-medicate or alter dosage
Side Effects
Increased uric acid levels Mild diarrhea or gastrointestinal upset Elevated liver enzymes (AST/ALT) Headache or dizziness Fatigue, mood changes (rare)
Contraindications
Pregnant or breastfeeding women Patients with severe renal or liver dysfunction Individuals with gout or hyperuricemia Known hypersensitivity to Favipiravir Use cautiously in elderly patients or those on multiple medications
Availability
Favipiravir 400 mg tablet uses Favipiravir COVID-19 treatment Antiviral tablet for flu Favipiravir dosage guide Favipiravir 400 mg side effects High strength antiviral for COVID Favipiravir 400 mg price Emergency antiviral medicine Oral antiviral for influenza RNA polymerase inhibitor drug